المؤلفون: Liu, Sixue, Knochelmann, Hannah M, Lomeli, Shirley H, Hong, Aayoung, Richardson, Mary, Yang, Zhentao, Lim, Raymond J, Wang, Yan, Dumitras, Camelia, Krysan, Kostyantyn, Timmers, Cynthia, Romeo, Martin J, Krieg, Carsten, O’Quinn, Elizabeth C, Horton, Joshua D, Dubinett, Steve M, Paulos, Chrystal M, Neskey, David M, Lo, Roger S

المصدر: Cell Reports Medicine. 2(10)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Clinical Research, Immunotherapy, Cancer, Dental/Oral and Craniofacial Disease, Health Disparities, Rare Diseases, Minority Health, Antineoplastic Agents, Immunological, Carcinoma, Squamous Cell, Cyclin-Dependent Kinase Inhibitor p16, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Humans, Immune Checkpoint Inhibitors, Janus Kinase 2, Mouth Neoplasms, Mutation, Neoadjuvant Therapy, Neoplasm Recurrence, Local, Nivolumab, PTEN Phosphohydrolase, Programmed Cell Death 1 Receptor, Receptors, Antigen, T-Cell, alpha-beta, Survival Analysis, T-Lymphocytes, Regulatory, Th17 Cells, Treatment Outcome, Vascular Endothelial Growth Factor Receptor-3, YAP-Signaling Proteins, FLT4/PTEN/PPARG/CDKN2A/YAP1/JAK2, T cell repertoire, T regulatory to Th17 ratio, head-and-neck cancer/oral-cavity SCC, multiplex immunofluorescence, neoadjuvant anti-PD-1/L1 therapy, recurrence-free survival, response, resistance, and recurrence, tumor mutational burden, tumor phylogeny, Biomedical and clinical sciences

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/6fz2m57k
https://escholarship.org/content/qt6fz2m57k/qt6fz2m57k.pdf

المؤلفون: Sixue Liu, Hannah M. Knochelmann, Shirley H. Lomeli, Aayoung Hong, Mary Richardson, Zhentao Yang, Raymond J. Lim, Yan Wang, Camelia Dumitras, Kostyantyn Krysan, Cynthia Timmers, Martin J. Romeo, Carsten Krieg, Elizabeth C. O’Quinn, Joshua D. Horton, Steve M. Dubinett, Chrystal M. Paulos, David M. Neskey, Roger S. Lo

المصدر: Cell Reports Medicine, Vol 2, Iss 10, Pp 100411- (2021)

مصطلحات موضوعية: neoadjuvant anti-PD-1/L1 therapy, head-and-neck cancer/oral-cavity SCC, response, resistance, and recurrence, FLT4/PTEN/PPARG/CDKN2A/YAP1/JAK2, T cell repertoire, T regulatory to Th17 ratio, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S266637912100269X; https://doaj.org/toc/2666-3791

URL الوصول: https://doaj.org/article/39a1c3a08dca431b9aeaf1eb80b12cdf

المؤلفون: Roger S. Lo, S. Dubinett, Elizabeth C O'Quinn, Shirley H. Lomeli, Hannah M. Knochelmann, Mary S. Richardson, Raymond J. Lim, Cynthia D Timmers, Sixue Liu, Camelia Dumitras, David M. Neskey, Carsten Krieg, Aayoung Hong, Yan Wang, Martin J. Romeo, Kostyantyn Krysan, Chrystal M. Paulos, Joshua D. Horton, Zhentao Yang

المصدر: Cell Reports Medicine
Cell Reports Medicine, Vol 2, Iss 10, Pp 100411-(2021)

مصطلحات موضوعية: Medicine (General), Receptors, Antigen, T-Cell, alpha-beta, Programmed Cell Death 1 Receptor, multiplex immunofluorescence, T-Lymphocytes, Regulatory, Antineoplastic Agents, Immunological, CDKN2A, Medicine, Immune Checkpoint Inhibitors, YAP1, biology, Neoadjuvant Therapy, Gene Expression Regulation, Neoplastic, Nivolumab, Treatment Outcome, tumor phylogeny, Carcinoma, Squamous Cell, Mouth Neoplasms, neoadjuvant anti-PD-1/L1 therapy, tumor mutational burden, General Biochemistry, Genetics and Molecular Biology, Article, R5-920, PTEN, Humans, recurrence-free survival, Oral Cavity Squamous Cell Carcinoma, Cyclin-Dependent Kinase Inhibitor p16, business.industry, Gene Expression Profiling, Head and neck cancer, T regulatory to Th17 ratio, PTEN Phosphohydrolase, FLT4/PTEN/PPARG/CDKN2A/YAP1/JAK2, YAP-Signaling Proteins, Janus Kinase 2, medicine.disease, Vascular Endothelial Growth Factor Receptor-3, FLT4, Survival Analysis, Blockade, Mutation, Cancer research, biology.protein, Th17 Cells, head-and-neck cancer/oral-cavity SCC, response, resistance, and recurrence, Neoplasm Recurrence, Local, business, T cell repertoire

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7443333c34cc2bdeb619d2819417f92b
http://europepmc.org/articles/PMC8561238